MENLO PARK, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT) today announced it will report financial results for the second quarter 2021 after the market close on Thursday, August 12, 2021. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https://investors.sightsciences.com/.
About Sight SciencesFounded in 2011, Sight Sciences is a growth stage medical device company focused on the development and commercialization of proprietary devices that target the underlying causes of the world's most prevalent eye diseases. The company currently markets two products, the OMNI ® Surgical System and the TearCare ® System. For more information, visit www.sightsciences.com .
OMNI ® and TearCare ® are registered trademarks of Sight Sciences.© 2021 Sight Sciences. All rights reserved.
Media contact:Shay SmithHealth+Commerce707.971.9779 email@example.com
Investor contact:Philip TaylorGilmartin Group415.937.5406 Investor.Relations@Sightsciences.com